However, immunohistochemical (IHC) analysis of a tissue microarray consisting of 147 invasive breast cancer samples and 44 normal breast tissue samples showed that GPRC5A is abundantly expressed in breast cancers, whereas no association was discovered between GPRC5A expression and clinicopathological characteristics [85]. This evidence concerns the gene GPRC5A and breast carcinoma.